Skip to main content

Advertisement

Log in

Triphenylphosphonium cations of betulinic acid derivatives: synthesis and antitumor activity

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

A series of lupane triterpenoid conjugates with the triphenylphosphonium cation, in which the terpenoid molecules are linked to one or two triphenylphosphonium moieties at the С-2, С-28, or С-30 positions by carbon–carbon or ester bonds, have been designed and synthesized as potential anti-cancer agents. The pharmacological results showed that all of the prepared triphenylphosphonium salts displayed considerable antitumor activities against the tested cancer murine tumor (Ehrlich ascites carcinoma, (Р-815), and human tumor (MCF-7) (IC50 < 2 μg/mL)) cell lines. The presence of the triphenylphosphonium cation in the triterpenoid conjugates markedly enhanced the cytotoxic action as compared to the parent compound (betulinic acid) (IC50 24.7 μg/mL for Ehrlich cells and 18.7 μg/mL for Р-815 cells), while the correlation between the cytotoxic activity and the chemical structure of phosphonium salts was not observed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Scheme 1
Scheme 2
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Alkhaldi AAM, Martinek J, Panicucci B, Dardonville C, Zikova A, Koning HP (2016) Trypanocidal action of bisphosphonium salts through a mitochondrial target in bloodstream form Trypanosoma brucei. Int J Parasitol 6:23–34

    Google Scholar 

  • Biedermann D, Eignerova B, Hajduch M, Sarek J (2010) Synthesis and evaluation of biological activity of the quaternary ammonium salts of lupane-, oleanane-, and ursane-type acids. Synthesis (Mass) 18:3839–3848

    Google Scholar 

  • Chintharlapalli S, Papineni S, Lei P, Pathi S, Safe S (2011) Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors. BMC Cancer 11:371–383

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cichewicz RA, Kouzi SA (2004) Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection. Med Res Rev 24:90–114

    Article  CAS  PubMed  Google Scholar 

  • Csuk R (2014) Betulinic acid and its derivatives: a patent review (2008–2013). Expert Opin Ther Patents 24:913–923

    Article  CAS  Google Scholar 

  • Damle AA, Pawar YP, Narkar AA (2013) Anticancer activity of betulinic acid on MCF-7 tumors in nude mice. Indian J Exper Biol 51:485–491

    CAS  Google Scholar 

  • Fetisova EK, Avetisyan AV, Izyumov DS, Korotetskaya MV, Chernyak BV, Skulachev VP (2010) Mitochondria-targeted antioxidant SkQR1 selectively protects MDR (Pgp 170)-negative cells against oxidative stress. FEBS Lett 584:562–566

    Article  CAS  PubMed  Google Scholar 

  • Fulda S (2008) Betulinic acid for cancer treatment and prevention. Int J Mol Sci 9:1096–1107

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fulda S, Kroemer G (2009) Targeting mitochondrial apoptosis by betulinic acid in human cancers. Drug Discov Today 14:885–890

    Article  CAS  PubMed  Google Scholar 

  • Fulda S (2009) Betulinic acid: A natural product with anticancer activity. Mol Nutr Food Res 53:140–146

    Article  CAS  PubMed  Google Scholar 

  • Fulda S, Galluzzi L, Kroemer G (2010) Targeting mitochondria for cancer therapy. Nat Rev Drug Discov 9:447–464

    Article  CAS  PubMed  Google Scholar 

  • Fulda S, Kroemer G (2011) Mitochondria as therapeutic targets for the treatment of malignant disease. Antioxid Redox Signal 15:2937–2949

    Article  CAS  PubMed  Google Scholar 

  • Han M, Vakili MR, Abyaneh HS, Molavi O, Lai R, Lavasanifar A (2014) Mitochondrial delivery of doxorubicin via triphenylphosphine modification for overcoming drug resistance in MDA-MB-435/DOX cells. Mol Pharm 11:2640–2649

    Article  CAS  PubMed  Google Scholar 

  • Jara JA, Castro-Castillo V, Saavedra-Olavarría J, Peredo L, Pavanni M, Jana F, Letelier ME, Parra E, Becker MI, Morello A, Kemmerling U, Maya JD, Ferreira J (2014) Antiproliferative and uncoupling effects of delocalized, lipophilic, cationic gallic acid derivatives on cancer cell lines. Validation in vivo in singenic mice. J Med Chem 57:2440–2454

    Article  CAS  PubMed  Google Scholar 

  • Jeong H-J, Chai HB, Park S-Y, Kim DSHL (1999) Preparation of amino acid conjugates of betulinic acid with activity against human melanoma. Bioorg Med Chem Lett 9:1201–1204

    Article  CAS  PubMed  Google Scholar 

  • Kessler JH, Mullauer FB, Roo GM, Medema JP (2007) Broad in vitro efficacy of plant-derived betulinic acid against cell lines derived from the most prevalent human cancer types. Cancer Lett 251:132–145

    Article  CAS  PubMed  Google Scholar 

  • Kim DSHL, Chen Z, Ngugen VT, Pezzuto JM, Qui S, Lu Z-Z (1997) A concise semi-synthetic approach to betulinic acid from betulin. Synth Commun 27:1607–1612

    Article  CAS  Google Scholar 

  • Kovarova J, Bajzikova M, Vondrusova M, Stursa J, Goodwin J, Nguyen M, Zobalova R, Pesdar EA, Truksa J, Tomasetti M, Dong L-F, Neuzil J (2014) Mitochondrial targeting of α-tocopheryl succinate enhances its anti-mesothelioma efficacy. Redox Rep 19:16–25

    Article  CAS  PubMed  Google Scholar 

  • Kuznetsova SA, Vasilèva NYu, Kalacheva GS, Titova NM, Red’kina ES, Skvortsova GP (2008) Obtaining betulin diacetate from the outer birch bark and studying it’s antioxidant activity. J Siberian Federal Univ Chem 2:151–165

    Google Scholar 

  • Kvasnica M, Sarek J, Klinotova E, Dzubak P, Hajduch M (2005) Synthesis of phthalates of betulinic acid and betulin with cytotoxic activity. Bioorg Med Chem 13:3447–3454

    Article  CAS  PubMed  Google Scholar 

  • Marrache S, Pathak RK, Dhar S (2014) Detouring of cisplatin to access mitochondrial genome for overcoming resistance. PNAS 111:10444–10449

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Modica-Napolitano JS, Kulawiec M, Singh KK (2007) Mitochondria and human cancer. Curr Mol Med 7:121–131

    Article  CAS  PubMed  Google Scholar 

  • Mukherjee R, Jaggi M, Rajendran P, Srivastava SK, Siddiqui MJAS, Vardhan A, Burman AC (2004) Synthesis of 3-O-acyl/3-benzylidene/3-hydrazone/3-hydrazine/17-carboxyacryloyl ester derivatives of betulinic acid as anti-angiogenic agents. Bioorg Med Chem Letters 14:3169–3172

    Article  CAS  Google Scholar 

  • Mukherjee R, Kumar V, Srivastava SK, Agarwal SK, Burman AC (2006) Betulinic acid derivatives as anticancer agents: structure activity relationship. Anti-Cancer Agents Med Chem 6:271–279

    Article  CAS  Google Scholar 

  • Mullauer FB, Bloois L, Daalhuisen JB, Brink MST, Storm G, Medema JP, Schiffelers RM, Kessler JH (2011) Betulinic acid delivered in liposomes reduces growth of human lung and colon cancers in mice without causing systemic toxicity. Anticancer Drugs 22:223–233

    Article  CAS  PubMed  Google Scholar 

  • Mullauer FB, Kessler JH, Medema JP (2010) Betulinic acid, a natural compound with potent anti-cancer effects. Anticancer Drugs 21:215–227

    Article  CAS  PubMed  Google Scholar 

  • Pisha E, Chai H, Lee IS, Chagwedera TE, Farnsworth NR, Cordell GA, Beecher CWW, Fong HHS, Kinghorn AD, Brown DM, Wani MC, Wall ME, Hieken TJ, Das Gupta TK, Pezzuto JM (1995) Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat Med 1:1046–1051

    Article  CAS  PubMed  Google Scholar 

  • Qian K, Yu D, Chen Ch-H, Huang L, Morris-Natschke SL, Nitz TJ, Salzwedel K, Reddick M, Allaway GP, Lee K-H (2009) Anti-AIDS agents. 78. Design, synthesis, metabolic stability assessment, and antiviral evaluation of novel betulinic acid derivatives as potent anti-human immunodeficiency virus (HIV) agents. J Med Chem 52:3248–3258

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Reddy CA, Somepalli V, Golakoti T, Kanugula AK, Karnewar S, Rajendiran K, Vasagiri N, Prabhakar S, Kuppusamy P, Kotamraju S, Kutala VK (2014) Mitochondrial-targeted curcuminoids: a strategy to enhance bioavailability and anticancer efficacy of curcumin. PLoS One 9:89351

    Article  Google Scholar 

  • Ross MF, Ros T, Blaikie FH, Prime TA, Porteous CM, Severina II, Skulachev VP, Kjaergaard HG, Smith RAJ, Murphy MP (2006) Accumulation of lipophilic dications by mitochondria and cells. Biochem J 400:199–208

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Santos RC, Salvador JAR, Marin S, Cascante M, Moreira JN, Dinis TCP (2010) Synthesis and structure–activity relationship study of novel cytotoxic carbamate and N-acylheterocyclic bearing derivatives of betulin and betulinic acid. Bioorg Med Chem 18:4385–4396

    Article  CAS  PubMed  Google Scholar 

  • Sarek J, Kvasnica M, Vik M, Urban M, Dzubak P, Hajduch M (2011) The potential of triterpenoids in the treatment of melanoma. In: Murph M (ed) Research on melanoma—a glimpse into current directions and future trends. In Tech, Rijeka, pp 125–158

    Google Scholar 

  • Severina II, Vyssokikh MY, Pustovidko AV, Simonyan RA, Rokitskaya TI, Skulachev VP (2007) Effects of lipophilic dications on planar bilayer phospholipids membrane and mitochondria. Biochim Biophys Acta 1767:1164–1168

    Article  CAS  PubMed  Google Scholar 

  • Skulachev VP, Anisimov VN, Antonenko YN, Bakeeva LE, Chernyak BV, Erichev VP, Filenko OF, Kalinina NI, Kapelko VI, Kolosova NG, Kopnin BP, Korshunova GA, Lichinitser MR, Obukhova LA, Pasyukova EG, Pisarenko OI, Roginsky VA, Ruuge EK, Senin II, Severina II, Skulachev MV, Spivak IM, Tashlitsky VN, Tkachuk VA, Vyssokik My, Yaguzhinsky LS, Zorov DB (2009) An attempt to prevent senescence: A mitochondrial approach. Biochim Biophys Acta 1787:437–461

    Article  CAS  PubMed  Google Scholar 

  • Smith RAJ, Hartley RC, Cocheme HM, Murphy MP (2012) Mitochondrial pharmacology. Trends Pharmacol Sci 33:341–352

    Article  CAS  PubMed  Google Scholar 

  • Spivak AYu, Nedopekina DA, Shakurova ER, Khalitova RR, Gubaidullin RR, Odinokov VN, Dzhemilev UM, Bel´skii YuP, Bel´skaya NV, Stankevich SA, Korotkaya EV, Khazanov VA (2013) Synthesis of lupane triterpenoids with triphenylphosphonium substituents and studies of their antitumor activity. Russ Chem Bull 62:188–198

    Article  CAS  Google Scholar 

  • Spivak AYu, Keiser J, Vargas M, Gubaidullin RR, Nedopekina DA, Shakurova ER, Khalitova RR, Odinokov VN (2014) Synthesis and activity of new triphenylphosphonium derivatives of betulin and betulinic acid against Schistosoma mansoni in vitro and in vivo. Bioorg Med Chem 22:6297–6304

    Article  CAS  PubMed  Google Scholar 

  • Strobykina IYu, Belenok MG, Semenova MN, Semenov VV, Babaev VM, Rizvanov IK, Mironov VF, Kataev VE (2015) Triphenylphosphonium cations of the diterpenoid isosteviol:synthesis and antimitotic activity in a sea urchin embryo model. J Nat Prod 78:1300–1308

    Article  CAS  PubMed  Google Scholar 

  • Uzenkova NV, Petrenko NI, Shakirov MM, Shul’ts EE, Tolstikov GA (2005) Synthesis of 30-amino derivatives of lupine triterpenoids. Chem Nat Comp 41:692–700

    Article  CAS  Google Scholar 

  • Yogeeswari P, Sriram D (2005) Betulinic acid and its derivatives: a review on their biological properties. Curr Med Chem 12:657–666

    Article  CAS  PubMed  Google Scholar 

  • Zuco V, Supino R, Righetti SC, Cleris L, Marchesi E, Gambacorti-Passerini C, Formelli F (2002) Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells. Cancer Lett 175:17–25

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors are deeply thankful to the staff members of the analytical center “Agidel” at Institute of Petrochemistry and Catalysis of RAS for spectral measurement. This work was performed under financial support from the Russian Science Foundation (Grant 16-13-10051).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anna Yu. Spivak.

Ethics declarations

Conflict of interest

The authors declare no Conflict of interest.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Spivak, A.Y., Nedopekina, D.A., Khalitova, R.R. et al. Triphenylphosphonium cations of betulinic acid derivatives: synthesis and antitumor activity. Med Chem Res 26, 518–531 (2017). https://doi.org/10.1007/s00044-016-1771-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-016-1771-z

Keywords

Navigation